Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights
12 November 2026, 16:00 - 17:00 GMT
This webinar is part of the 'Cutting Edge Innovation in Clinical & Experimental PH’ sessions, which takes place bi-monthly on the second Thursday at 16:00 GMT/BST. Each session features keynote talks and discussion from senior experts in the field as well as young and mid-level investigators.
Presentations
- Validation of biomarkers for clinical use: methological challenges and the path forward
Anna Hemnes, Vanderbilt University - Use of the plasma proteosome for risk stratifying patients with PAH
Christopher J. Rhodes, National Heart and Lung Institute, Imperial College - NOTCH3-ECD as a Biomarker for PAH
Patricia A. Thistlethwaite, University of California - Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension
Mona Alotaibi, University of California San Diego - Blood endostatin, a Collagen18a1 fragment, as markers of vascular dysfunction in PAH
Grazyna Kwapiszewska, University of Graz
Moderated by Patricia A. Thistlethwaite – University of California.
The PVRI Digital Webinar Series is open to everyone to attend and we encourage active audience participation.
More from PVRI Digital Webinar Series
The PVRI Digital Webinar Series enables our worldwide community the opportunity to connect and learn cutting-edge new research. The live webinars are open to everyone to attend and offer ample time for questions to encourage active audience participation. Recordings are uploaded to our website for our members to watch.